Key Developments: Codexis Inc (CDXS.O)
2.61USD
18 Jun 2013
$-0.05 (-1.88%)
$2.66
$2.66
$2.69
$2.47
258,593
154,386
$4.00
$1.99
Latest Key Developments (Source: Significant Developments)
Codexis Inc Reaffirms FY 2013 Revenue Guidance
Codexis Inc announced that for fiscal 2013, it expects revenue in the range of $35 million to $40 million. Full Article
Codexis Inc Issues FY 2013 Revenue Guidance Below Analysts' Estimates
Codexis Inc announced that for fiscal 2013, it expects revenue in the range of $35 million to $40 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $53 million for fiscal 2013. Full Article
Albany Molecular Research Inc Announces Technology Collaboration With Codexis Inc
Albany Molecular Research Inc and Codexis Inc announced that they have entered into a SMARTSOURCING partnership. The collaboration will provide opportunities to combine the two companies' capabilities and technologies for specific customer projects, yielding increased value to customers in the form of potentially lower costs, greater yields, cleaner processes and/or faster turnaround times. Under this non-exclusive, two-year agreement, the companies will align their respective strengths to identify and implement new and improved manufacturing routes for selected Active Pharmaceutical Ingredients (APIs). Combining Codexis' directed evolution technology that enables rapid enzyme discovery and optimization with AMRI's process development and manufacturing capabilities, including utilizing AMRI's microbial strains, creates synergies that will broaden both companies' ability to offer customers cost-effective, efficient and sustainable manufacturing processes. Full Article
Codexis Inc Reaffirms FY 2012 Guidance Reaffirms FY 2012 Guidance
Codexis Inc announced that for fiscal 2012, it expects a decline in total revenues relative to fiscal 2011 total revenues of $124 million and adjusted EBITDA to be negative. Full Article
Codexis Inc Appoints David O’Toole as Chief Financial Officer (CFO)
Codexis Inc announced the appointment of David O’Toole as Senior Vice President and Chief Financial Officer (CFO), effective September 4, 2012. Full Article
Codexis Inc Updates FY 2012 Revenue Guidance; Lowers FY 2012 EBITDA Guidance
Codexis Inc announced that for fiscal 2012, it expects total revenues of $124 million. The company also now expects fiscal 2012 Adjusted EBITDA to be negative. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $126 million and EBITDA of $(9.38) million for fiscal 2012. Full Article
Codexis Inc Announces Interim CFO Departure
Codexis Inc announced that Brian Dowd has resigned as interim Chief Financial Officer (CFO), Vice President and Controller, effective June 28, 2012, in order to accept a position at a private technology company. Full Article
Codexis Inc Appoints John J. Nicols as President and Chief Executive Officer
Codexis Inc announced the appointment of John J. Nicols as President and Chief Executive Officer. Mr. Nicols will begin his new role on June 13, 2012. Mr. Nicols will be appointed to the Company's Board of Directors following the commencement of his employment as President and Chief Executive Officer. Full Article
Codexis, Inc. Announces Three Year Extension Of Collaboration Agreement With Merck
Codexis, Inc. announced a three-year extension of its catalyst and process development collaboration with Merck to develop enzymes for use in pharmaceutical manufacturing. As the collaboration enters its sixth year, Merck will continue to use Codexis’ enzyme products to develop more cost- and resource-efficient manufacturing processes for its pipeline of therapeutic candidates. The initial agreement was announced in April 2007 and now agreement provides an extension to 2015. Full Article
Codexis, Inc. Reaffirms FY 2012 Guidance
Codexis, Inc. reaffirmed fiscal 2012 guidance and forecasts revenues in line with or exceeding fiscal 2011 results. The Company expects fiscal 2012 adjusted EBITDA to be positive. The Company reported revenues of $123.9 million in fiscal 2011. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $128 million for fiscal 2012. Full Article
Earnings vs. 
Estimates
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
